Bristol Myers Squibb (BMY) Consolidated Net Income (2009 - 2026)

Bristol Myers Squibb (BMY) has reported Consolidated Net Income for 18 consecutive years, with $3.3 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Consolidated Net Income rose 152.55% year-over-year to $3.3 billion in Q2 2026; TTM through Jun 2026 was $9.3 billion, a 83.1% increase from a year earlier, with the FY2025 full-year figure at $7.1 billion, up 178.99% from the prior year.
• Consolidated Net Income was $3.3 billion for Q2 2026 at Bristol Myers Squibb, up from $2.7 billion in the prior quarter.
• Over five years, Consolidated Net Income peaked at $3.3 billion in Q2 2026 and troughed at -$11.9 billion in Q1 2024.
• A 5-year average of $1.0 billion and a median of $1.7 billion in 2023 frame the typical range for Consolidated Net Income.
• Across the five-year window, Consolidated Net Income slumped 625.28% in 2024 and surged 1328.95% in 2025, its largest moves.
• Over 5 years, Consolidated Net Income stood at $2.0 billion in 2022, then slipped by 12.99% to $1.8 billion in 2023, then slumped by 95.69% to $76.0 million in 2024, then surged by 1328.95% to $1.1 billion in 2025, then soared by 205.34% to $3.3 billion in 2026.
• The last three Consolidated Net Income figures came in at $3.3 billion (Q2 2026), $2.7 billion (Q1 2026), and $1.1 billion (Q4 2025), per Business Quant data.